ヒストプラズマ症(Histoplasmosis):世界の治験レビュー(2014年下半期版)

◆英語タイトル:Histoplasmosis Global Clinical Trials Review, H2, 2014
◆商品コード:GDHC2453CTIDB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2014年11月30日
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥520,000見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD7,500 ⇒換算¥780,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、世界におけるヒストプラズマ症(Histoplasmosis) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - ヒストプラズマ症(Histoplasmosis)
  - 当レポートの概要
・ヒストプラズマ症(Histoplasmosis):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Histoplasmosis Global Clinical Trials Review, H2, 2014

Summary

GlobalData’s clinical trial report, “Histoplasmosis Global Clinical Trials Review, H2, 2014″ provides data on the Histoplasmosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Histoplasmosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Histoplasmosis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Histoplasmosis 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Histoplasmosis to Infectious Disease Clinical Trials 10
Clinical Trials in G7 Countries by Trial Status 11
Clinical Trials by Phase 12
In Progress Trials by Phase 13
Clinical Trials by Trial Status 14
Clinical Trials by End Point Status 15
Subjects Recruited Over a Period of Time 16
Clinical Trials by Sponsor Type 17
Prominent Sponsors 18
Top Companies Participating in Histoplasmosis Therapeutics Clinical Trials 19
Prominent Drugs 20
Clinical Trial Profiles 21
Clinical Trial Overview of Top Companies 21
Novartis AG 21
Clinical Trial Overview of Novartis AG 21
Johnson & Johnson 22
Clinical Trial Overview of Johnson & Johnson 22
Janssen Pharmaceuticals, Inc. 23
Clinical Trial Overview of Janssen Pharmaceuticals, Inc. 23
Chemo Espana, S.A. 24
Clinical Trial Overview of Chemo Espana, S.A. 24
Clinical Trial Overview of Top Institutes / Government 25
The National Institute of Allergy and Infectious Diseases 25
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 25
National Eye Institute 26
Clinical Trial Overview of National Eye Institute 26
National Center for Research Resources 27
Clinical Trial Overview of National Center for Research Resources 27
Retina Research Institute of Texas, LLC 28
Clinical Trial Overview of Retina Research Institute of Texas, LLC 28
Retina Associates of Kentucky 29
Clinical Trial Overview of Retina Associates of Kentucky 29
Barnes Retina Institute 30
Clinical Trial Overview of Barnes Retina Institute 30
Five Key Clinical Profiles 31
Appendix 52
Abbreviations 52
Definitions 52
Research Methodology 53
Secondary Research 53
About GlobalData 54
Contact Us 54
Disclaimer 54
Source 54

List of Tables
Histoplasmosis Therapeutics, Global, Clinical Trials by Region, 2014* 6
Histoplasmosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 7
Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 8
Histoplasmosis Therapeutics Clinical Trials, North America, Top Countries, 2014* 9
Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 10
Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 11
Histoplasmosis Therapeutics, Global, Clinical Trials by Phase, 2014* 12
Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 13
Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Histoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
Histoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 16
Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 17
Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
Histoplasmosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 20
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 21
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 22
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Pharmaceuticals, Inc., 2014* 23
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chemo Espana, S.A., 2014* 24
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014* 25
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2014* 26
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 27
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Research Institute of Texas, LLC, 2014* 28
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Retina Associates of Kentucky, 2014* 29
Histoplasmosis Therapeutics Clinical Trials Market, Global, Clinical Trials by Barnes Retina Institute, 2014* 30

List of Figures
Histoplasmosis Therapeutics, Global, Clinical Trials by Region (%), 2014* 6
Proportion of Histoplasmosis to Infectious Disease Clinical Trials, G7 Countries (%), 2014* 10
Histoplasmosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 11
Histoplasmosis Therapeutics, Global, Clinical Trials by Phase (%), 2014* 12
Histoplasmosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 13
Histoplasmosis Therapeutics, Global, Clinical Trials by Trial Status, 2014* 14
Histoplasmosis Therapeutics Clinical Trials, Global, by End Point Status, 2014* 15
Histoplasmosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 16
Histoplasmosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 17
Histoplasmosis Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 18
Histoplasmosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 19
GlobalData Methodology 53

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[ヒストプラズマ症(Histoplasmosis):世界の治験レビュー(2014年下半期版)]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆